Top 5 FDA-Cleared Apps for Primary Care

June 12th 2025

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

High discontinuation rates as well as lower maintenance dosages of semaglutide and tirzepatide were among the independent predictors of lower real-world weight loss.

Sydney Jennings;Elizabeth Mollard, PhD

May 22nd 2025

George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

June 10th 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The novel triple fixed-dose combination of telmisartan, amlodipine and indapamide, is the first of its kind approved for initial treatment of hypertension.

August 30th 2023

Social Determinants of Health Affect Use of HRT During Menopause, Study Suggests

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Social Determinants of Health Affect Use of HRT Use During Menopause, Study Suggests / image credit ©BillionPhotos.com/stock.adobe.com

Postpartum Hormonal Contraceptives Up Depression Risk by 50%: Daily Dose

Social determinants including partner status, smoking history, and BMI were significantly associated with reduced access to effective hormone therapy for menopausal women.

High Discontinuation Rates of GLP-1 RA-Based Drugs Linked to Weight Loss Far Below Phase 3 Clinical Trials

Your daily dose of the clinical news you may have missed.

Related Content

June 12th 2025

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

High discontinuation rates as well as lower maintenance dosages of semaglutide and tirzepatide were among the independent predictors of lower real-world weight loss.

Sydney Jennings;Elizabeth Mollard, PhD

May 22nd 2025

George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

June 10th 2025

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

The novel triple fixed-dose combination of telmisartan, amlodipine and indapamide, is the first of its kind approved for initial treatment of hypertension.

August 30th 2023

Social Determinants of Health Affect Use of HRT During Menopause, Study Suggests

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Postpartum Hormonal Contraceptives Up Depression Risk by 50%: Daily Dose

Social determinants including partner status, smoking history, and BMI were significantly associated with reduced access to effective hormone therapy for menopausal women.